CAS: 1382979-44-3
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
2-Pyrimidinamine, 5-[8,9-dihydro-6,6-dimethyl-4-(4-morpholinyl)-6H-[1,4]oxazino[4,3-e]purin-2-yl]- REF: AN-AG0018GRCAS: 1382979-44-3 | 95% | A consultar | Lun 13 May 24 | |
GDC0084 REF: TM-T3705CAS: 1382979-44-3 | 99.16% | 58,00 €~1.486,00 € | Mar 21 May 24 | |
GDC 0084 REF: 3D-FD145121CAS: 1382979-44-3 | Min. 95% | A consultar | Mar 25 Jun 24 |
2-Pyrimidinamine, 5-[8,9-dihydro-6,6-dimethyl-4-(4-morpholinyl)-6H-[1,4]oxazino[4,3-e]purin-2-yl]-
CAS:1382979-44-3
Fórmula:
C18H22N8O2
Pureza:
95%
Forma y color:
Solid
Peso molecular:
382.4197
Ref: AN-AG0018GR
1g | A consultar | |
5mg | 47,00 € | |
10mg | 59,00 € | |
25mg | 112,00 € | |
50mg | 157,00 € | |
100mg | 189,00 € | |
250mg | 319,00 € |
Entrega estimada en Estados Unidos, el Lunes 13 de Mayo de 2024
GDC0084
CAS:1382979-44-3
GDC0084 (RG7666) is a PI3K inhibitor with potential antineoplastic activity. GDC0084 (RG7666) specifically inhibits PI3K …
Fórmula:
C18H22N8O2
Pureza:
99.16%
Forma y color:
Solid
Peso molecular:
382.42
Ref: TM-T3705
1mg | 58,00 € | |
2mg | 72,00 € | |
5mg | 119,00 € | |
10mg | 184,00 € | |
25mg | 377,00 € | |
50mg | 490,00 € | |
100mg | 708,00 € | |
500mg | 1.486,00 € | |
1ml*10 (DMSO) | 119,00 € |
Entrega estimada en Estados Unidos, el Martes 21 de Mayo de 2024
GDC 0084
CAS:1382979-44-3
PI3K and mTOR enzyme inhibitor; anti-cancer agent
Fórmula:
C18H22N8O2
Pureza:
Min. 95%
Peso molecular:
382.42 g/mol
Ref: 3D-FD145121
1mg | A consultar | |
2mg | A consultar | |
5mg | A consultar | |
10mg | A consultar | |
25mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 25 de Junio de 2024